Home › Funds › Boston Partners › IQV
Boston Partners position in IQV
IQVIA HLDGS INC · Health Care
Boston Partners reported holding 4,368,759 shares of IQV (IQVIA HLDGS INC) in its Q3 2026 13F filing — a position valued at US$1.17B, representing 1.05% of its reported portfolio and ranking #12 among its reported holdings. Boston Partners has disclosed IQV holdings in 10 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Boston Partners's IQV position evolved
Boston Partners first disclosed a stake in IQV in Q3 2023 at 454,351 shares (US$89.4M). The position peaked in Q3 2026 at 4,368,759 shares, worth US$1.17B. Across 10 filings, Boston Partners increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 4,368,759 shares valued at US$1.17B — a reduction of -97,257 shares quarter over quarter.. Notable position changes include a 99% trim in Q4 2023 (shares rose 9% over the following quarter), a 149% increase in Q2 2024 (shares rose 12% over the following quarter), a 78% trim in Q3 2024 (shares fell 17% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 454.35K | $89.38M | New |
| Q4 2023 | 3.35K | $774.66K | Reduce |
| Q1 2024 | 3.08K | $779.15K | Reduce |
| Q2 2024 | 7.67K | $1.62M | Add |
| Q3 2024 | 1.66K | $392.18K | Reduce |
| Q3 2025 | 3.56M | $676.70M | New |
| Q4 2025 | 4.09M | $923.28M | Add |
| Q1 2026 | 4.24M | $723.31M | Add |
| Q2 2026 | 4.47M | $865.50M | Add |
| Q3 2026 | 4.37M | $1.17B | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IQV and 13F data
IQV (IQVIA HLDGS INC) is a Health Care company. 24 other funds we track also report a position in IQV — the largest reported positions include Harris Associates (Oakmark) (US$2.35B), HARRIS ASSOCIATES L P (US$2.35B), Artisan Partners Limited Partnership (US$930.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IQV
- Harris Associates (Oakmark) 12.18M sh · $2.35B · Q2 2026
- HARRIS ASSOCIATES L P 12.18M sh · $2.35B · Q2 2026
- Artisan Partners Limited Partnership 3.46M sh · $930.59M · Q3 2026
- WCM INVESTMENT MANAGEMENT, LLC 2.67M sh · $717.70M · Q3 2026
- LYRICAL ASSET MANAGEMENT LP 1.25M sh · $337.08M · Q3 2026
More on Boston Partners
FAQ
How long has Boston Partners held IQV?
Boston Partners has disclosed IQV holdings in 10 of the last 13 reported quarters, going back to Q3 2023.
What is Boston Partners's current position in IQV?
As of Q3 2026, Boston Partners holds 4.37M shares of IQV (IQVIA HLDGS INC), valued at $1.17B, representing 1.05% of its reported portfolio and ranking #12.
Has Boston Partners been buying or selling IQV?
In the latest 13F filing (Q3 2026), Boston Partners reduced its position in IQV. The position peaked in Q3 2026 at 4.37M shares.
Which other funds hold IQV?
Other major institutional holders of IQV include Harris Associates (Oakmark), HARRIS ASSOCIATES L P, Artisan Partners Limited Partnership, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.